Profile data is unavailable for this security.
About the company
Mabpharm Ltd is China-based company mainly engaged in the research, development and production of monoclonal antibody drugs for cancers and autoimmune diseases. The Company's main products include omalizumab (CMAB007), cetuximab (CMAB009) and infliximab (CMAB008). The Company mainly conducts its businesses in China market.
- Revenue in HKD (TTM)94.18m
- Net income in HKD-226.23m
- Incorporated2018
- Employees347.00
- LocationMabpharm LtdBlock G79, Lujia Road East, Koutai RoadTaizhou 225300ChinaCHN
- Websitehttp://www.mabpharm.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhongzhi Pharmaceutical Holdings Ltd | 2.21bn | 175.89m | 991.86m | 2.64k | 5.53 | 0.8754 | 3.45 | 0.4478 | 0.2077 | 0.2077 | 2.62 | 1.31 | 1.12 | 2.53 | 10.54 | 838,056.70 | 8.95 | 7.69 | 14.15 | 11.75 | 59.73 | 60.56 | 8.01 | 6.73 | 0.894 | -- | 0.1424 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | 3.22 |
| CStone Pharmaceuticals | 501.22m | -396.83m | 1.13bn | 230.00 | -- | 2.29 | -- | 2.25 | -0.3146 | -0.3146 | 0.3968 | 0.3844 | 0.2811 | 2.44 | 3.72 | 2,179,208.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| Jacobson Pharma Corporation Ltd | 1.68bn | 212.16m | 1.14bn | 1.59k | 5.12 | 0.4779 | 2.88 | 0.6774 | 0.1112 | 0.1409 | 0.8822 | 1.19 | 0.3722 | 2.87 | 7.50 | 940,829.50 | 5.16 | 4.91 | 6.61 | 6.60 | 42.05 | 41.81 | 13.85 | 14.32 | 1.01 | 5.62 | 0.3646 | 35.97 | 11.91 | 2.89 | 41.30 | 4.42 | -6.22 | 6.39 |
| VIVA Biotech Holdings | 2.33bn | -125.47m | 1.14bn | 2.08k | -- | 0.2845 | 9.46 | 0.4912 | -0.0638 | -0.0638 | 1.20 | 1.86 | 0.2805 | 4.84 | 5.13 | 1,121,460.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 0.035 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | -- | -- |
| Essex Bio-Technology Ltd | 1.71bn | 275.26m | 1.31bn | 1.48k | 4.91 | 0.6786 | 3.90 | 0.7649 | 0.4689 | 0.4689 | 2.87 | 3.39 | 0.6161 | 2.28 | 3.35 | 1,152,300.00 | 9.94 | 11.20 | 13.21 | 14.73 | 90.20 | 86.01 | 16.13 | 19.77 | 1.46 | -- | 0.1326 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
| Ascletis Pharma Inc | 61.16m | -156.38m | 1.31bn | 219.00 | -- | 0.5503 | -- | 21.50 | -0.147 | -0.147 | 0.0569 | 2.36 | 0.022 | 2.30 | 3.86 | 279,253.20 | -5.62 | -6.43 | -5.91 | -6.64 | 45.92 | 35.67 | -255.70 | -243.38 | 16.54 | -6.09 | 0.0036 | -- | 4.63 | -19.39 | 54.04 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 68.64m | -388.06m | 1.34bn | 301.00 | -- | 1.15 | -- | 19.49 | -0.5020 | -0.5020 | 0.0888 | 1.46 | 0.0419 | -- | 5.21 | 228,034.50 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| TOT Biopharm International Co Ltd | 843.53m | -40.80m | 1.34bn | 463.00 | -- | 1.81 | 354.17 | 1.59 | -0.0563 | -0.0563 | 1.16 | 0.9602 | 0.5808 | 1.87 | 7.75 | -- | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | -- | -- |
| Wuhan YZY Biopharma Co Ltd | -100.00bn | -100.00bn | 1.44bn | 123.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1.50 | -- | -- | -- |
| Mabpharm Ltd | 94.18m | -226.23m | 1.65bn | 347.00 | -- | 7.44 | -- | 17.49 | -0.0549 | -0.0549 | 0.0228 | 0.0537 | 0.0893 | 0.1176 | 6.02 | 271,424.60 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| Hua Medicine | 82.78m | -228.26m | 1.68bn | 177.00 | -- | 14.22 | -- | 20.25 | -0.2335 | -0.2335 | 0.0847 | 0.1117 | 0.0538 | 1.69 | 1.98 | 467,701.40 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -361.80m | 1.69bn | 210.00 | -- | 9.01 | -- | -- | -0.7031 | -0.7031 | 0.00 | 0.3646 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -1.97 | 0.4327 | -- | -- | -- | -5.25 | -- | -- | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.24bn | 352.27m | 1.77bn | 1.14k | 5.03 | 0.5732 | 3.91 | 1.42 | 0.2344 | 0.2344 | 0.8278 | 2.06 | 0.3156 | 2.31 | 6.37 | 1,088,279.00 | 8.85 | 9.89 | 11.36 | 12.49 | 54.60 | 56.69 | 28.03 | 27.89 | 2.26 | 28.89 | 0.0405 | 35.33 | -9.90 | 3.94 | -8.95 | 1.41 | 63.92 | 2.00 |
| Acotec Scientific Holdings Ltd | 512.03m | 15.65m | 1.93bn | 638.00 | 118.36 | 1.38 | 29.42 | 3.77 | 0.0521 | 0.0521 | 1.70 | 4.47 | 0.3136 | 0.7213 | 3.44 | 802,555.20 | 0.9589 | -- | 1.03 | -- | 79.65 | -- | 3.06 | -- | 9.12 | 2.75 | 0.1529 | -- | 19.80 | -- | -79.35 | -- | -- | -- |
| SinoMab Bioscience Ltd | 1.47m | -262.70m | 2.05bn | 233.00 | -- | 6.08 | -- | 1,389.74 | -0.258 | -0.258 | 0.0015 | 0.3086 | 0.0015 | -- | -- | -- | -26.20 | -24.62 | -32.50 | -27.72 | 30.92 | -- | -17,810.33 | -4,451.74 | -- | -8.15 | 0.604 | -- | -- | -- | 14.45 | -- | -- | -- |
| Cutia Therapeutics | 148.71m | -2.12bn | 2.23bn | 298.00 | -- | 1.52 | -- | 14.98 | -18.26 | -18.26 | 0.7268 | 4.79 | -- | -- | -- | 499,035.30 | -- | -- | -- | -- | 51.60 | -- | -1,426.91 | -- | 5.38 | -- | 0.153 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
Data as of May 02 2024. Currency figures normalised to Mabpharm Ltd's reporting currency: Hong Kong Dollar HKD
18.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| CDH Investment Advisory Pte. Ltd.as of 30 Jun 2023 | 742.35m | 18.00% |
Data from 31 Jul 2023 - 31 Jul 2023Source: FactSet Research Systems Inc.
